EcoDrugPlus

Insulin-Like Growth Factor 1b Receptor

Ensembl ID : ENSOKIG00005034209
Gene Symbol: IGF1RB
1 Cross references
202 Possible Orthologues:

Integrin Alpha-4

Ensembl ID : ENSOKIG00005026481
Gene Symbol: LOC109890729
2 Cross references
164 Possible Orthologues:

Integrin Alpha-5

Ensembl ID : ENSOKIG00005029763
Gene Symbol: LOC109869387
3 Cross references
200 Possible Orthologues:

Integrin Alpha-5-Like

Ensembl ID : ENSOKIG00005019139
Gene Symbol: LOC109908216
3 Cross references
200 Possible Orthologues:

Integrin Alpha-Iib

Ensembl ID : ENSOKIG00005011009
Gene Symbol: LOC109893208
3 Cross references
183 Possible Orthologues:

Integrin Alpha-V-Like

Ensembl ID : ENSOKIG00005001157
Gene Symbol: LOC109881272
3 Cross references
230 Possible Orthologues:

Integrin Beta-1

Ensembl ID : ENSOKIG00005035587
Gene Symbol: LOC109899549
3 Cross references
209 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSOKIG00005038904
Gene Symbol: LOC109898406
3 Cross references
195 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSOKIG00005024207
Gene Symbol: LOC109893301
3 Cross references
195 Possible Orthologues:

Integrin Beta-5

Ensembl ID : ENSOKIG00005012644
Gene Symbol: LOC109871245
3 Cross references
204 Possible Orthologues:

Integrin Beta-7

Ensembl ID : ENSOKIG00005000625
Gene Symbol: LOC109895826
2 Cross references
144 Possible Orthologues:

Integrin Beta-7

Ensembl ID : ENSOKIG00005048341
Gene Symbol: LOC109908339
2 Cross references
133 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).